| 1 | [SID93576602] | Active | EC50 | 0.0137 | Luminescence-based cell-based high throughput dose response assay for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) [AID624503, Type: confirmatory] | Htr2a gene product [Mus musculus] [gi:27753985] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 93576602 | | CID | 45479730 | | Outcome | Active | | EC50 | 0.0137 [uM] | | BioAssay | Luminescence-based cell-based high throughput dose response assay for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) | | AID | 624503 | | BioAssay type | confirmatory | | Target | Htr2a gene product [Mus musculus] [gi:27753985] | | PubMed | | | Data Table |  |
|
| 2 | [SID93576602] | Active | EC50 | 0.0137 | Luminescence-based cell-based high throughput dose response assay for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) [AID624503, Type: confirmatory] | Htr2a gene product [Mus musculus] [gi:27753985] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 93576602 | | CID | 45479730 | | Outcome | Active | | EC50 | 0.0137 [uM] | | BioAssay | Luminescence-based cell-based high throughput dose response assay for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) | | AID | 624503 | | BioAssay type | confirmatory | | Target | Htr2a gene product [Mus musculus] [gi:27753985] | | PubMed | | | Data Table |  |
|
| 3 | [SID93576602] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) [AID624169, Type: screening] | Htr2a gene product [Mus musculus] [gi:27753985] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 93576602 | | CID | 45479730 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) | | AID | 624169 | | BioAssay type | screening | | Target | Htr2a gene product [Mus musculus] [gi:27753985] | | PubMed | | | Data Table |  |
|
| 4 | [SID93576602] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) [AID624169, Type: screening] | Htr2a gene product [Mus musculus] [gi:27753985] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 93576602 | | CID | 45479730 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) | | AID | 624169 | | BioAssay type | screening | | Target | Htr2a gene product [Mus musculus] [gi:27753985] | | PubMed | | | Data Table |  |
|
| 5 | [SID93576602] | Active | | | uHTS identification of inhibitors of cullin neddylation in a TR-FRET assay [AID651699, Type: screening] | NAE1 gene product [Homo sapiens] [gi:4502169] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 93576602 | | CID | 45479730 | | Outcome | Active | | BioAssay | uHTS identification of inhibitors of cullin neddylation in a TR-FRET assay | | AID | 651699 | | BioAssay type | screening | | Target | NAE1 gene product [Homo sapiens] [gi:4502169] | | PubMed | | | Data Table |  |
|
| 6 | [SID93576602] | Active | | | Luminescence-based cell-based high throughput confirmation assay for agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID504915, Type: screening] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 93576602 | | CID | 45479730 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 504915 | | BioAssay type | screening | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 7 | [SID93576602] | Active | | | Luminescence-based cell-based high throughput confirmation assay for agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID504915, Type: screening] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 93576602 | | CID | 45479730 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 504915 | | BioAssay type | screening | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 8 | [SID93576602] | Active | | | Luminescence-based cell-based high throughput confirmation assay for agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID504915, Type: screening] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 93576602 | | CID | 45479730 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 504915 | | BioAssay type | screening | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 9 | [SID93576602] | Active | | | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) [AID652257, Type: screening] | PRMT1 protein [Homo sapiens] [gi:32425330] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 93576602 | | CID | 45479730 | | Outcome | Active | | BioAssay | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) | | AID | 652257 | | BioAssay type | screening | | Target | PRMT1 protein [Homo sapiens] [gi:32425330] | | PubMed | | | Data Table |  |
|
| 10 | [SID93576602] | Active | | | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) [AID652257, Type: screening] | PRMT1 protein [Homo sapiens] [gi:32425330] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 93576602 | | CID | 45479730 | | Outcome | Active | | BioAssay | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) | | AID | 652257 | | BioAssay type | screening | | Target | PRMT1 protein [Homo sapiens] [gi:32425330] | | PubMed | | | Data Table |  |
|
| 11 | [SID93576602] | Active | | | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID504692, Type: screening] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 93576602 | | CID | 45479730 | | Outcome | Active | | BioAssay | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 504692 | | BioAssay type | screening | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 12 | [SID93576602] | Active | | | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID504692, Type: screening] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 93576602 | | CID | 45479730 | | Outcome | Active | | BioAssay | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 504692 | | BioAssay type | screening | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 13 | [SID93576602] | Active | | | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID504692, Type: screening] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 93576602 | | CID | 45479730 | | Outcome | Active | | BioAssay | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 504692 | | BioAssay type | screening | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 14 | [SID93576602] | Active | | | Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen [AID652039, Type: screening] | KLK7 gene product [Homo sapiens] [gi:21327705] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 93576602 | | CID | 45479730 | | Outcome | Active | | BioAssay | Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen | | AID | 652039 | | BioAssay type | screening | | Target | KLK7 gene product [Homo sapiens] [gi:21327705] | | PubMed | | | Data Table |  |
|
| 15 | [SID93576602] | Active | | | Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen [AID652039, Type: screening] | KLK7 gene product [Homo sapiens] [gi:21327705] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 93576602 | | CID | 45479730 | | Outcome | Active | | BioAssay | Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen | | AID | 652039 | | BioAssay type | screening | | Target | KLK7 gene product [Homo sapiens] [gi:21327705] | | PubMed | | | Data Table |  |
|
| 16 | [SID93576602] | Active | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Agonists [AID624465, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 93576602 | | CID | 45479730 | | Outcome | Active | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Agonists | | AID | 624465 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 17 | [SID93576602] | Active | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Agonists [AID624465, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 93576602 | | CID | 45479730 | | Outcome | Active | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Agonists | | AID | 624465 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 18 | [SID93576602] | Active | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Agonists [AID624465, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 93576602 | | CID | 45479730 | | Outcome | Active | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Agonists | | AID | 624465 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 19 | [SID93576602] | Active | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Agonists [AID624465, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 93576602 | | CID | 45479730 | | Outcome | Active | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Agonists | | AID | 624465 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 20 | [SID93576602] | Active | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Agonists [AID624465, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 93576602 | | CID | 45479730 | | Outcome | Active | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Agonists | | AID | 624465 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 21 | [SID93576602] | Active | | | qHTS of D3 Dopamine Receptor Agonist: qHTS [AID652048, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 93576602 | | CID | 45479730 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Agonist: qHTS | | AID | 652048 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 22 | [SID93576602] | Active | | | qHTS of D3 Dopamine Receptor Agonist: qHTS [AID652048, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 93576602 | | CID | 45479730 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Agonist: qHTS | | AID | 652048 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 23 | [SID93576602] | Active | | | qHTS of D3 Dopamine Receptor Agonist: qHTS [AID652048, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 93576602 | | CID | 45479730 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Agonist: qHTS | | AID | 652048 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 24 | [SID93576602] | Active | | | qHTS of D3 Dopamine Receptor Agonist: qHTS [AID652048, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 93576602 | | CID | 45479730 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Agonist: qHTS | | AID | 652048 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 25 | [SID93576602] | Active | | | qHTS of D3 Dopamine Receptor Potentiators: qHTS [AID652051, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 93576602 | | CID | 45479730 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Potentiators: qHTS | | AID | 652051 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 26 | [SID93576602] | Active | | | qHTS of D3 Dopamine Receptor Potentiators: qHTS [AID652051, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 93576602 | | CID | 45479730 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Potentiators: qHTS | | AID | 652051 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 27 | [SID93576602] | Active | | | qHTS of D3 Dopamine Receptor Potentiators: qHTS [AID652051, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 93576602 | | CID | 45479730 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Potentiators: qHTS | | AID | 652051 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 28 | [SID93576602] | Active | | | qHTS of D3 Dopamine Receptor Potentiators: qHTS [AID652051, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 93576602 | | CID | 45479730 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Potentiators: qHTS | | AID | 652051 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 29 | [SID93576602] | Active | | | TRFRET-based biochemical primary high throughput screening assay to identify small molecules that bind to the HIV-1-gp120 binding antibody, PG9 [AID624416, Type: screening] | Envelope surface glycoprotein gp160, precursor [Human immunodeficiency virus 1] [gi:9629363] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 93576602 | | CID | 45479730 | | Outcome | Active | | BioAssay | TRFRET-based biochemical primary high throughput screening assay to identify small molecules that bind to the HIV-1-gp120 binding antibody, PG9 | | AID | 624416 | | BioAssay type | screening | | Target | Envelope surface glycoprotein gp160, precursor [Human immunodeficiency virus 1] [gi:9629363] | | PubMed | | | Data Table |  |
|
| 30 | [SID93576602] | Active | | | Counterscreen for discovery of small molecules that bind to the HIV-1-gp120 binding antibody, PG9: TR-FRET-based biochemical high throughput assay to identify small molecules that bind to the control antibody, PGV04, which binds to a site on the HIV envelope different from the PG9 binding site [AID651604, Type: screening] | Envelope surface glycoprotein gp160, precursor [Human immunodeficiency virus 1] [gi:9629363] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 93576602 | | CID | 45479730 | | Outcome | Active | | BioAssay | Counterscreen for discovery of small molecules that bind to the HIV-1-gp120 binding antibody, PG9: TR-FRET-based biochemical high throughput assay to identify small molecules that bind to the control antibody, PGV04, which binds to a site on the HIV envelope different from the PG9 binding site | | AID | 651604 | | BioAssay type | screening | | Target | Envelope surface glycoprotein gp160, precursor [Human immunodeficiency virus 1] [gi:9629363] | | PubMed | | | Data Table |  |
|
| 31 | [SID93576602] | Active | | | TRFRET-based biochemical high throughput confirmation assay for small molecules that bind to the HIV-1-gp120 binding antibody, PG9 [AID651571, Type: screening] | Envelope surface glycoprotein gp160, precursor [Human immunodeficiency virus 1] [gi:9629363] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 93576602 | | CID | 45479730 | | Outcome | Active | | BioAssay | TRFRET-based biochemical high throughput confirmation assay for small molecules that bind to the HIV-1-gp120 binding antibody, PG9 | | AID | 651571 | | BioAssay type | screening | | Target | Envelope surface glycoprotein gp160, precursor [Human immunodeficiency virus 1] [gi:9629363] | | PubMed | | | Data Table |  |
|
| 32 | [SID93576602] | Active | | | Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis [AID588726, Type: screening] | Probable fructose-bisphosphate aldolase Fba [Mycobacterium tuberculosis H37Rv] [gi:15607504] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 93576602 | | CID | 45479730 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis | | AID | 588726 | | BioAssay type | screening | | Target | Probable fructose-bisphosphate aldolase Fba [Mycobacterium tuberculosis H37Rv] [gi:15607504] | | PubMed | | | Data Table |  |
|
| 33 | [SID93576602] | Active | | | Luminescence-based cell-based high throughput confirmation assay for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) [AID624381, Type: screening] | Htr2a gene product [Mus musculus] [gi:27753985] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 93576602 | | CID | 45479730 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) | | AID | 624381 | | BioAssay type | screening | | Target | Htr2a gene product [Mus musculus] [gi:27753985] | | PubMed | | | Data Table |  |
|
| 34 | [SID93576602] | Active | | | Luminescence-based cell-based high throughput confirmation assay for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) [AID624381, Type: screening] | Htr2a gene product [Mus musculus] [gi:27753985] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 93576602 | | CID | 45479730 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) | | AID | 624381 | | BioAssay type | screening | | Target | Htr2a gene product [Mus musculus] [gi:27753985] | | PubMed | | | Data Table |  |
|
| 35 | [SID93576602] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 93576602 | | CID | 45479730 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 36 | [SID93576602] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 93576602 | | CID | 45479730 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 37 | [SID93576602] | Inactive | Potency | 31.6228 | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588453, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 93576602 | | CID | 45479730 | | Outcome | Inactive | | Potency | 31.6228 [uM] | | BioAssay | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588453 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 38 | [SID93576602] | Inactive | Potency | 31.6228 | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588453, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 93576602 | | CID | 45479730 | | Outcome | Inactive | | Potency | 31.6228 [uM] | | BioAssay | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588453 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 39 | [SID93576602] | Inactive | Potency | 50.1187 | qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588456, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 93576602 | | CID | 45479730 | | Outcome | Inactive | | Potency | 50.1187 [uM] | | BioAssay | qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588456 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 40 | [SID93576602] | Inactive | Potency | 50.1187 | qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588456, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 93576602 | | CID | 45479730 | | Outcome | Inactive | | Potency | 50.1187 [uM] | | BioAssay | qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588456 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 41 | [SID93576602] | Inactive | Potency | 89.1251 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 93576602 | | CID | 45479730 | | Outcome | Inactive | | Potency | 89.1251 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 42 | [SID93576602] | Inactive | Potency | 89.1251 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 93576602 | | CID | 45479730 | | Outcome | Inactive | | Potency | 89.1251 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 43 | [SID93576602] | Inactive | EC50 | 92.507 | Counterscreen for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A): Luminescence-based cell-based high throughput dose response assay to identify agonists of the mu 1 opioid receptor (OPRM1) [AID624499, Type: confirmatory] | OPRM1 gene product [Homo sapiens] [gi:117940060] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 93576602 | | CID | 45479730 | | Outcome | Inactive | | EC50 | 92.507 [uM] | | BioAssay | Counterscreen for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A): Luminescence-based cell-based high throughput dose response assay to identify agonists of the mu 1 opioid receptor (OPRM1) | | AID | 624499 | | BioAssay type | confirmatory | | Target | OPRM1 gene product [Homo sapiens] [gi:117940060] | | PubMed | | | Data Table |  |
|
| 44 | [SID93576602] | Inactive | EC50 | 92.507 | Counterscreen for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A): Luminescence-based cell-based high throughput dose response assay to identify agonists of the mu 1 opioid receptor (OPRM1) [AID624499, Type: confirmatory] | OPRM1 gene product [Homo sapiens] [gi:117940060] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 93576602 | | CID | 45479730 | | Outcome | Inactive | | EC50 | 92.507 [uM] | | BioAssay | Counterscreen for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A): Luminescence-based cell-based high throughput dose response assay to identify agonists of the mu 1 opioid receptor (OPRM1) | | AID | 624499 | | BioAssay type | confirmatory | | Target | OPRM1 gene product [Homo sapiens] [gi:117940060] | | PubMed | | | Data Table |  |
|
| 45 | [SID93576602] | Inactive | EC50 | 92.507 | Counterscreen for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A): Luminescence-based cell-based high throughput dose response assay to identify agonists of the mu 1 opioid receptor (OPRM1) [AID624499, Type: confirmatory] | OPRM1 gene product [Homo sapiens] [gi:117940060] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 93576602 | | CID | 45479730 | | Outcome | Inactive | | EC50 | 92.507 [uM] | | BioAssay | Counterscreen for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A): Luminescence-based cell-based high throughput dose response assay to identify agonists of the mu 1 opioid receptor (OPRM1) | | AID | 624499 | | BioAssay type | confirmatory | | Target | OPRM1 gene product [Homo sapiens] [gi:117940060] | | PubMed | | | Data Table |  |
|
| 46 | [SID93576602] | Inactive | EC50 | 92.507 | Counterscreen for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A): Luminescence-based cell-based high throughput dose response assay to identify agonists of the mu 1 opioid receptor (OPRM1) [AID624499, Type: confirmatory] | OPRM1 gene product [Homo sapiens] [gi:117940060] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 93576602 | | CID | 45479730 | | Outcome | Inactive | | EC50 | 92.507 [uM] | | BioAssay | Counterscreen for agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A): Luminescence-based cell-based high throughput dose response assay to identify agonists of the mu 1 opioid receptor (OPRM1) | | AID | 624499 | | BioAssay type | confirmatory | | Target | OPRM1 gene product [Homo sapiens] [gi:117940060] | | PubMed | | | Data Table |  |
|
| 47 | [SID93576602] | Inactive | | | Turbidometric Biochemical Primary HTS to identify inhibitors of Protein Disulfide Isomerase Measured in Biochemical System Using Plate Reader - 2137-01_Inhibitor_SinglePoint_HTS_Activity [AID588391, Type: screening] | Prolyl 4-hydroxylase, beta polypeptide [Homo sapiens] [gi:14790033] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 93576602 | | CID | 45479730 | | Outcome | Inactive | | BioAssay | Turbidometric Biochemical Primary HTS to identify inhibitors of Protein Disulfide Isomerase Measured in Biochemical System Using Plate Reader - 2137-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 588391 | | BioAssay type | screening | | Target | Prolyl 4-hydroxylase, beta polypeptide [Homo sapiens] [gi:14790033] | | PubMed | | | Data Table |  |
|
| 48 | [SID93576602] | Inactive | | | Turbidometric Biochemical Primary HTS to identify inhibitors of Protein Disulfide Isomerase Measured in Biochemical System Using Plate Reader - 2137-01_Inhibitor_SinglePoint_HTS_Activity [AID588391, Type: screening] | Prolyl 4-hydroxylase, beta polypeptide [Homo sapiens] [gi:14790033] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 93576602 | | CID | 45479730 | | Outcome | Inactive | | BioAssay | Turbidometric Biochemical Primary HTS to identify inhibitors of Protein Disulfide Isomerase Measured in Biochemical System Using Plate Reader - 2137-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 588391 | | BioAssay type | screening | | Target | Prolyl 4-hydroxylase, beta polypeptide [Homo sapiens] [gi:14790033] | | PubMed | | | Data Table |  |
|
| 49 | [SID93576602] | Inactive | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (PAFAH1B2) [AID492953, Type: screening] | platelet-activating factor acetylhydrolase IB subunit beta isoform b [Homo sapiens] [gi:296080766] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 93576602 | | CID | 45479730 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (PAFAH1B2) | | AID | 492953 | | BioAssay type | screening | | Target | platelet-activating factor acetylhydrolase IB subunit beta isoform b [Homo sapiens] [gi:296080766] | | PubMed | | | Data Table |  |
|
| 50 | [SID93576602] | Inactive | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1B, catalytic subunit 3 (PAFAH1B3) [AID492972, Type: screening] | platelet-activating factor acetylhydrolase IB subunit gamma [Homo sapiens] [gi:225543099] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 93576602 | | CID | 45479730 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1B, catalytic subunit 3 (PAFAH1B3) | | AID | 492972 | | BioAssay type | screening | | Target | platelet-activating factor acetylhydrolase IB subunit gamma [Homo sapiens] [gi:225543099] | | PubMed | | | Data Table |  |
|